TIDES Europe 2026 has ended. This guide stays up as the record of who was there. See upcoming conferences

Zealand Pharma at TIDES Europe 2026

Nov 3–5, 2026 Amsterdam, Netherlands ~900 attendees Website

Zealand Pharma takes part in 2 sessions at TIDES Europe 2026 in Amsterdam. Its sessions cover peptide medicines for metabolic disease, from process development to translational research. With Bachem it traces dapiglutide from the lab to large-scale manufacture, and it also explores a selective amylin receptor agonist.

OrganizationTIDES Europe 2026 Attendance
Zealand Pharma
Søborg, Denmark
Biotech
Danish biotech developing peptide medicines for obesity and metabolic diseases, including amylin and GLP-1 analogues.
Talk
Wed Nov 4
16:15–16:45
Dapiglutide: From Lab to Large Scale Manufacture through Innovative Peptide Process Development
How process changes in making the peptide drug dapiglutide raised its overall yield from about 20% to over 60%.
with Bachem
Talk
Fri Nov 6
10:30–10:55
Presentation: Exploring A Selective Amylin Receptor Agonist for Metabolic Disease
Post-event symposium: Clinical & Translational Updates

Explore the full TIDES Europe 2026 dataset

Get in-depth attendee and institution profiles and research, to plan your meetings in Amsterdam. Leave your work email and we’ll be in touch.

Privacy

Download the full TIDES Europe 2026 CSV

Leave your work email and we’ll be in touch. The CSV adds attendee names, roles and contact details to the company and session data shown here.

Privacy

Find decision makers at Zealand Pharma

Tell us what you sell and we’ll find the people at Zealand Pharma most likely to buy it.

  • Who to contact
  • Their contact info
  • What to say
  • Free, no sign-up

Not affiliated with or endorsed by TIDES Europe or its organizers. Submit a correction